The devices, which brace the spines of children with scoliosis, were the subject of recalls in 2020. The company reportedly fixed the previous mechanical issues. However, the FDA has since received complaints about other risks associated with the devices. Although…

There’s a phrase in economics known as the tragedy of the commons. It describes scenarios in which individuals’ short-term selfish interests are at odds with long-term group interests and the common good. Water rights are a prime, real-world example of…

The outcome of the case is a stark reminder of the importance of expert witness testimony during medical malpractice cases. Experts are a necessity in a vast majority of cases. They need to be prepared to offer clear, accurate, and…

The parties in the Google antitrust lawsuit are currently going through an onerous discovery process that includes demands for Microsoft to produce documents. With a trial date of September 12, 2023, this case is likely to be in our periphery…

Zoom recently agreed to pay $85 million to settle claims that the company misrepresented its end-to-end encryption on video calls. According to the claim, the company shared user data with other entities, including Facebook and Google, without users’ consent. The…

Zantac’s History Zantac, and its generic name, ranitidine, have been on the market since 1983 for the treatment of heartburn and acid reflux. By 1988, it was one of the world’s top-selling drugs, earning $1 billion in annual sales. By…

The Facts of the Case The class action filed on behalf of the class by Klaudia Sekura was the underlying lawsuit. Sekura was a one-time member of Krishna Schaumburg Tan Inc., a tanning salon. Under the terms of the membership,…

For companies who have been closely monitoring news about consumer data privacy laws, the CPA may not surprise them. However, it isn’t an exact copy of the CPRA or VCDPA. Businesses will have to evaluate whether the new Colorado data…

The motion sought dismissal of the case, Elizabeth Kahn v. Sanofi S.A., et al., 16-CV-17039. This case is part of multidistrict litigation pending before the District Court in the Eastern District of Louisiana against Sanofi and other drugmakers. The Kahn…

The Case Between Novartis and Plexxikon In 2005, Plexxikon began developing compounds intended to slow the growth of cancer cells in some types of skin cancer. Plexxikon later applied for and was granted patents for the compounds. In partnership with…